ONCR-021

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameONCR-021
Drug Alias NameONCR-021
ClassificationBiologics > Oncolytic virusSmall molecules > Nucleosides and nucleotide derivtives > RNA
Mechanisms of ActionCell death stimulantsImmunostimulantsImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLiver NeoplasmsCarcinoma, Renal Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncorus Inc
China Registration ClassN/A

Develop Information

Active CompaniesOncorus Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungLiver NeoplasmsCarcinoma, Renal Cell +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A